T. Rowe Price Associates’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $20.3M | Buy |
|
|||||
|
2019
Q4 | $25.4M | Buy |
|
|||||
|
2019
Q3 | $24.5M | Buy |
|
|||||
|
2019
Q2 | $7.11M | Buy |
|
|||||
|
2019
Q1 | $793K | Buy |
|
|||||
|
2018
Q4 | $716K | Buy |
|
|||||
|
2018
Q3 | $312K | Sell |
|
|||||
|
2018
Q2 | $404K | Sell |
|
|||||
|
2018
Q1 | $604K | Sell |
|
|||||
|
2017
Q4 | $662K | Buy |
|
|||||
|
2017
Q3 | $222K | Hold |
|
|||||
|
2017
Q2 | $204K | Buy |
|
|||||
|
2017
Q1 | $213K | Hold |
|
|||||
|
2016
Q4 | $195K | Hold |
|
|||||
|
2016
Q3 | $143K | Sell |
|
|||||
|
2016
Q2 | $373K | Buy |
|
|||||
|
2016
Q1 | $313K | Buy |
|
|||||
|
2015
Q4 | $326K | Buy |
|
|||||
|
2015
Q3 | $272K | Buy |
|
|||||
|
2015
Q2 | $294K | Hold |
|
|||||
|
2015
Q1 | $236K | Hold |
|
|||||
|
2014
Q4 | $298K | Sell |
|
|||||
|
2014
Q3 | $292K | Buy |
|
|||||
|
2014
Q2 | $177K | Hold |
|
|||||
|
2014
Q1 | $168K | Hold |
|
|||||
|
2013
Q4 | $219K | Hold |
|
|||||
|
2013
Q3 | $207K | Hold |
|
|||||
|
2013
Q2 | $183K | Buy |
|